GenVec, Inc. (NASDAQ: GNVC) will provide a presentation at the BIO CEO & Investor Conference. The company's President and CEO, Paul H. Fischer, Ph.D., will host their presentation at the event.
GenVec has been scheduled to make their presentation on February 8th at 1:30pm (EST). The event is being held in NYC at the Waldorf Astoria Hotel. A webcast of the presentation will be made available both live and for replay through the company's website.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade™, is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
